Search Results - "Ayari, Sameh"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Immunomodulation by Lymphodepletion and Donor Lymphocyte Infusion to Treat Post Allogeneic Transplantation Relapse by Guillaume, Thierry, Gaugler, Béatrice, Chevallier, Patrice, Ayari, Sameh, Delaunay, Jacques, Moreau, Philippe, Mohty, Mohamad

    Published in Blood (19-11-2010)
    “…Abstract 2084 Relapse of hematologic malignancies following allogeneic hematopoietic stem cell transplantation (HSCT) remains a major cause of treatment…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: A pilot series by Chevallier, Patrice, Pigneux, Arnaud, Robillard, Nelly, Ayari, Sameh, Guillaume, Thierry, Delaunay, Jacques, Eveillard, Marion, Dumas, Pierre-Yves, Lippert, Eric, Mohty, Mohamad, Leguay, Thibaut

    Published in Leukemia research (01-03-2012)
    “…Abstract No series have reported the results of the use of the therapeutic anti-CD20 monoclonal antibody (Rituximab) in the setting of adult…”
    Get full text
    Journal Article
  9. 9

    Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity by Guillaume, Thierry, Chevallier, Patrice, Ayari, Sameh, Delaunay, Jacques, Mechinaud, Francoise, Moreau, Philippe, Mohty, Mohamad

    Published in Blood (20-11-2009)
    “…Abstract 3033 Poster Board II-1009▪▪This icon denotes an abstract that is clinically relevant. Donor lymphocyte infusion (DLI) approach alone for treatment of…”
    Get full text
    Journal Article
  10. 10

    Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma by Ayari, Sameh, Mohty, Mohamad, Bilger, Karin, Guillerm, Gaelle, Guyotat, Denis, Michallet, Mauricette, Ifrah, Norbert, Chevallier, Patrice

    Published in Blood (20-11-2009)
    “…Abstract 3305 Poster Board III-193▪▪This icon denotes an abstract that is clinically relevant. Patients with breast carcinoma who received Radio and/or…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    5-Azacytidine (5-AZA) Salvage Therapy for Very High Risk Acute Myeloid Leukemia (AML): Response After 3 Cycles Is the Major Determinant for Outcome by Ayari, Sameh, Chevallier, Patrice, Guillaume, Thierry, Brissot, Eolia, Gouill, Steven Le, Mohty, Mohamad, Blin, Nicolas, Gastinne, Thomas, Moreau, Philippe, Harousseau, Jean Luc, Delaunay, Jacques

    Published in Blood (20-11-2009)
    “…Abstract 2044 Poster Board II-21 Very high risk AML can be categorized into three groups: i) group I: AML in second relapse or refractory after 2 induction…”
    Get full text
    Journal Article
  20. 20